The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects - PubMed (original) (raw)

PMID: 3993694

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects

M G Aman et al. Am J Ment Defic. 1985 Mar.

Abstract

The development of a scale to assess drug and other treatment effects on severely mentally retarded individuals was described. In the first stage of the project, an initial scale encompassing a large number of behavior problems was used to rate 418 residents. The scale was then reduced to an intermediate version, and in the second stage, 509 moderately to profoundly retarded individuals were rated. Separate factor analyses of the data from the two samples resulted in a five-factor scale comprising 58 items. The factors of the Aberrant Behavior Checklist have been labeled as follows: (I) Irritability, Agitation, Crying; (II) Lethargy, Social Withdrawal; (III) Stereotypic Behavior; (IV) Hyperactivity, Noncompliance; and (V) Inappropriate Speech. Average subscale scores were presented for the instrument, and the results were compared with empirically derived rating scales of childhood psychopathology and with factor analytic work in the field of mental retardation.

PubMed Disclaimer

Cited by

Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
Ghaleiha A, Mohammadi E, Mohammadi MR, Farokhnia M, Modabbernia A, Yekehtaz H, Ashrafi M, Hassanzadeh E, Akhondzadeh S. Ghaleiha A, et al. Paediatr Drugs. 2013 Dec;15(6):505-14. doi: 10.1007/s40272-013-0036-2. Paediatr Drugs. 2013. PMID: 23821414 Clinical Trial.
Co-occurring Down Syndrome and Autism Spectrum Disorder: Cognitive, Adaptive, and Behavioral Characteristics.
Bradbury KR, Anderberg EI, Huang-Storms L, Vasile I, Greene RK, Duvall SW. Bradbury KR, et al. J Autism Dev Disord. 2022 Mar;52(3):1235-1246. doi: 10.1007/s10803-021-05016-6. Epub 2021 Apr 27. J Autism Dev Disord. 2022. PMID: 33905067
Treatment of Autism Spectrum Disorder in Children and Adolescents.
DeFilippis M, Wagner KD. DeFilippis M, et al. Psychopharmacol Bull. 2016 Aug 15;46(2):18-41. Psychopharmacol Bull. 2016. PMID: 27738378 Free PMC article.
Integrative Care for Challenging Behaviors in People with Intellectual Disabilities to Reduce Challenging Behaviors and Inappropriate Psychotropic Drug Prescribing Compared with Care as Usual: A Cluster-Randomized Trial.
de Kuijper G, Jonker J, Kouwer K, Hoekstra PJ, de Bildt A. de Kuijper G, et al. Int J Environ Res Public Health. 2024 Jul 20;21(7):950. doi: 10.3390/ijerph21070950. Int J Environ Res Public Health. 2024. PMID: 39063526 Free PMC article. Clinical Trial.
A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome.
Kolevzon A, Bush L, Wang AT, Halpern D, Frank Y, Grodberg D, Rapaport R, Tavassoli T, Chaplin W, Soorya L, Buxbaum JD. Kolevzon A, et al. Mol Autism. 2014 Dec 12;5(1):54. doi: 10.1186/2040-2392-5-54. eCollection 2014. Mol Autism. 2014. PMID: 25685306 Free PMC article.

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects - PubMed (original) (raw)